
Ruxolitinib cream for paediatric AD: no new safety signals
Shownotes
Editor's Pick: 52-Week Safety and Disease Control With Ruxolitinib Cream in Children Aged 2 to 11 Years With Atopic Dermatitis: Results From the Phase 3 TRuE-AD3 Study (Journal of the American Academy of Dermatology, 2026)
This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice.
Welcome to This Week in Dermatology. This week we're covering 10 notable papers spanning cutaneous oncology and immunotherapy, long-term management of inflammatory skin disease, and the harder edges of blistering, metabolic and genetic skin conditions. Let's dive in.
This week's papers:
- Relatlimab plus nivolumab versus nivolumab for advanced melanoma: 5-year survival and biomarker analyses of the phase 3 RELATIVITY-047 trial.. Nature Medicine 2026
- Intralesional cemiplimab for patients with early-stage cutaneous squamous cell carcinoma: Results from a dose-escalation study with expansion cohorts.. Journal of the American Academy of Dermatology 2026
- Targeted and Immune-Based Therapies in Cutaneous T-Cell Lymphomas: A Systematic Review and Meta-Analysis.. JAMA Dermatology 2026
- A randomised double-blind placebo-controlled trial of topical menthol for pain relief during photodynamic therapy.. Clinical and Experimental Dermatology 2026
- 52-Week Safety and Disease Control With Ruxolitinib Cream in Children Aged 2 to 11 Years With Atopic Dermatitis: Results From the Phase 3 TRuE-AD3 Study.. Journal of the American Academy of Dermatology 2026
- Phenome-wide Longitudinal Association Study of Hospital-recorded Comorbidity in Psoriasis.. British Journal of Dermatology 2026
- Vitamin D status and systemic inflammatory burden as a predictor of biologic treatment response in psoriasis -A pilot study in Northern Ireland.. Clinical and Experimental Dermatology 2026
- Site-Specific Treatment and Remission Patterns in Multisite Mucous Membrane Pemphigoid.. JAMA Dermatology 2026
- Estrogen Use and Porphyria Cutanea Tarda.. JAMA Dermatology 2026
- Understanding the Experiences and Needs of Parents With Children With Epidermolysis Bullosa. A Qualitative Study to Inform the Development of a Self-help Toolkit.. British Journal of Dermatology 2026